The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer

Richard J. Rebello, Eric Kusnadi, Donald P. Cameron, Helen B. Pearson, Analia Lesmana, Jennifer R. Devlin, Denis Drygin, Ashlee K. Clark, Laura Porter, John Pedersen, Shahneen Sandhu, Gail P. Risbridger, Richard B. Pearson*, Ross D. Hannan, Luc Furic

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    64 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science